SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-172679
Filing Date
2024-07-01
Accepted
2024-07-01 06:07:56
Documents
16
Period of Report
2024-07-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d847398d8k.htm   iXBRL 8-K 31486
2 EX-1.1 d847398dex11.htm EX-1.1 205771
3 EX-5.1 d847398dex51.htm EX-5.1 6947
7 GRAPHIC g847398g0629053815110.jpg GRAPHIC 2538
  Complete submission text file 0001193125-24-172679.txt   439556

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bior-20240701.xsd EX-101.SCH 2868
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bior-20240701_lab.xml EX-101.LAB 18737
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bior-20240701_pre.xml EX-101.PRE 11719
18 EXTRACTED XBRL INSTANCE DOCUMENT d847398d8k_htm.xml XML 3778
Mailing Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122
Business Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122 855-293-2639
BIORA THERAPEUTICS, INC. (Filer) CIK: 0001580063 (see all company filings)

IRS No.: 273950390 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39334 | Film No.: 241087985
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)